OrbiMed Advisors »

Savara shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Savara (SVRA) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Savara

Tip: Access up to 7 years of quarterly data

All positions including Savara held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Savara by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5M 635k 5.46

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Avita Therapeutics (RCEL)
Mdxhealth Sa Shs New Call Option (MDXH)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Boston Scientific Corporation (BSX)
Sionna Therapeutics (SION)
Astrazeneca Ord (AZN)
Myriad Genetics (Principal) (MYGN)
Mbx Biosciences (MBX)
Corvus Pharmaceuticals (CRVS)
Argenx Se Sponsored Adr (ARGX)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)

View all positions for OrbiMed Advisors

Top funds holding Savara

NEA Management Company
Bain Capital Life Sciences Investors
VR Adviser
Deerfield Management Company
TCG Crossover Management
BlackRock
Vanguard Group
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Capital Management
Nantahala Capital Management
Rtw Investments
Marshall Wace
State Street Corporation
Woodline Partners

View all funds holding Savara